Adage Capital Partners Gp, L.L.C. Precision Biosciences Inc Transaction History

Adage Capital Partners Gp, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $155,250 - $450,900	-135,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.96 - $7.76 $488,400 - $1.28 Million	-165,000 Reduced 55.0%	135,000 $416,000
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $185,000 - $291,500	-25,000 Reduced 7.69%	300,000 $2.22 Million
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $2.98 Million - $4.6 Million	325,000 New	325,000 $3.75 Million
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $1.01 Million - $3 Million	-200,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.32 - $19.66 $4.43 Million - $13.8 Million	-701,276 Reduced 77.81%	200,000 $2.78 Million
Q2 2019 Aug 14, 2019	SELL	$11.88 - $16.94 $11 - $16	-1 Reduced -0.0%	901,276 $11.9 Million
Q1 2019 May 15, 2019	BUY	$17.44 - $17.95 $15.7 Million - $16.2 Million	901,277 New	901,277 $16.2 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $632M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.